BBC icon

Virtus LifeSci Biotech Clinical Trials ETF

18 hedge funds and large institutions have $7.19M invested in Virtus LifeSci Biotech Clinical Trials ETF in 2022 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 0 increasing their positions, 6 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
18
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$8K
2 +$6K
3 +$3K

Top Sellers

1 -$379K
2 -$264K
3 -$226K
4
FTUS
Flow Traders U.S.
New York
-$210K
5
Morgan Stanley
Morgan Stanley
New York
-$22.3K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$2.79M
2
$2.38M
3
$1.06M
4
$530K
5
$188K
6
$72K
7
$47K
8
$28K
9
$23.4K
10
$18K
11
$17K
12
$8K
13
$6K
14
$6K
15
$3K
16
$3K
17
$1K
18
19
20